These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 27940017
1. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Lu CH, Chen SH, Chang YS, Liu YW, Wu JY, Lim YP, Yu HI, Lee YR. Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017 [Abstract] [Full Text] [Related]
2. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Ishikawa C, Arbiser JL, Mori N. Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179 [Abstract] [Full Text] [Related]
6. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang X, Shen S. Cell Death Dis; 2018 Feb 06; 9(2):157. PubMed ID: 29410403 [Abstract] [Full Text] [Related]
8. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK. Cancer Lett; 2009 May 18; 277(2):133-40. PubMed ID: 19135778 [Abstract] [Full Text] [Related]
9. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J. Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872 [Abstract] [Full Text] [Related]
10. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells. Chou HC, Lu CH, Su YC, Lin LH, Yu HI, Chuang HH, Tsai YT, Liao EC, Wei YS, Yang YT, Chien YA, Yu XR, Lee YR, Chan HL. Life Sci; 2018 Aug 15; 207():184-204. PubMed ID: 29883720 [Abstract] [Full Text] [Related]
11. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Chilampalli C, Guillermo R, Kaushik RS, Young A, Chandrasekher G, Fahmy H, Dwivedi C. Exp Biol Med (Maywood); 2011 Nov 15; 236(11):1351-9. PubMed ID: 21908486 [Abstract] [Full Text] [Related]
12. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer. Tang H, Zhang Y, Li D, Fu S, Tang M, Wan L, Chen K, Liu Z, Xue L, Peng A, Ye H, Chen L. Eur J Med Chem; 2018 Aug 05; 156():190-205. PubMed ID: 30006164 [Abstract] [Full Text] [Related]
14. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy. Zhao M, Zheng YH, Zhao QY, Zheng W, Yang JH, Pei HY, Liu L, Liu KJ, Xue LL, Deng DX, Wang L, Ma X, Fu SH, Peng AH, Tang MH, Luo YZ, Ye HY, Chen LJ. Eur J Med Chem; 2021 Jan 01; 209():112922. PubMed ID: 33069436 [Abstract] [Full Text] [Related]
15. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis. Lin CJ, Chang YA, Lin YL, Liu SH, Chang CK, Chen RM. Phytomedicine; 2016 May 15; 23(5):517-27. PubMed ID: 27064011 [Abstract] [Full Text] [Related]
17. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. Lee B, Kim CH, Moon SK. FEBS Lett; 2006 Oct 02; 580(22):5177-84. PubMed ID: 16962592 [Abstract] [Full Text] [Related]
18. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas. Cheng YC, Hueng DY, Huang HY, Chen JY, Chen Y. Oncotarget; 2016 May 17; 7(20):29116-30. PubMed ID: 27074557 [Abstract] [Full Text] [Related]